1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Marketing & Advertising

King Bio Recalls Due To Potential Microbial Contamination Approach 500

 
• By Malcolm Spicer

FDA deemed 469 homeopathic remedies manufactured by King Bio – marketed as Dr. King’s: Natural Medicine, Aquaflora, SafeCareRx and Safecare bands – and recalled since July as class I, indicating the agency considers that a violative product poses reasonable probability of serious adverse health consequences or death. Kingston Pharma recalls one lot of DG/health Naturals baby Cough Syrup + Mucus potentially contaminated and Ata Int.'s BlueFusion product marketed as a dietary supplement contains ED ingredients and other drugs.

detailed illustration of a compass with Recall text, eps10 vector

The number of products that homeopathic drug manufacturer King Bio Inc. has recalled since July 2018 due to potential microbial contamination is approaching 500, according to the latest update to FDA's recalls database.

In other consumer health product recalls, on March 20 Kingston Pharma LLC announced that one lot of DG/health Naturals baby...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

OLLY Argues Standard Of Support For Kids Chillax Claims Casts Chill Over Supplement Advertising

 
• By Malcolm Spicer

NAD and NARB track their decisions on support for ad claims with Federal Trade Commission policies, including the requirement of RCTs to support health claims for supplements, a standard the industry argues is required for drug claims and shouldn’t be applied for dietary ingredients.

Astaxanthin Specialist AstaReal Diversifies With Garlic Supplement For Heart Health

 
• By Tom Gallen

Swedish producer of antioxidant astaxanthin AstaReal has expanded its product offering with cardiovascular health focused-brand Kyolic.

ProBiotix Health Looks To Next Level In Korea’s $450m Probiotics Market

 
• By Tom Gallen

Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

 
• By Tom Gallen

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

More from Business

Poland’s Formeds Acquired By Private Equity

 
• By Tom Gallen

Enterprise Investors takes 77% stake in Polish clean-label dietary supplements manufacturer Formeds.

BioGaia Takes Probiotics To Netherlands For First Time

 
• By Tom Gallen

Adopting an online approach, BioGaia is set to enter the Dutch market for probiotic dietary supplements. The firm announced the move as it reported lower sales in Q1.

US Consumer Health, Beauty Sectors: Expecting Tariff Policy Changes, Buckling Up For The Ride

 
• By Malcolm Spicer

As firms in OTC drug, dietary supplement and personal care/beauty sectors reported results for January-March period after Trump announced reciprocal tariffs, they buckled up for more changes in the president’s thinking likely to affect consumer spending as well as their costs.